William B. O'Connor

2014

In 2014, William B. O'Connor earned a total compensation of $1.2M as Chief Financial Officer at Medicines, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$183,094
Option Awards$318,871
Salary$393,750
Stock Awards$320,897
Other$3,214
Total$1,219,826

O'Connor received $393.8K in salary, accounting for 32% of the total pay in 2014.

O'Connor also received $183.1K in non-equity incentive plan, $318.9K in option awards, $320.9K in stock awards and $3.2K in other compensation.

Rankings

In 2014, William B. O'Connor's compensation ranked 6,695th out of 13,032 executives tracked by ExecPay. In other words, O'Connor earned more than 48.6% of executives.

ClassificationRankingPercentile
All
6,695
out of 13,032
49th
Division
Manufacturing
2,454
out of 4,965
51st
Major group
Chemicals And Allied Products
826
out of 1,690
51st
Industry group
Drugs
649
out of 1,369
53rd
Industry
Pharmaceutical Preparations
494
out of 1,042
53rd
Source: SEC filing on April 26, 2017.

O'Connor's colleagues

We found four more compensation records of executives who worked with William B. O'Connor at Medicines in 2014.

2014

Clive Meanwell

Medicines

Chief Executive Officer

2014

Cornelis Heiman

Medicines

Former Executive Vice President and Chief Innovation Officer

2014

Victoria Kusiak

Medicines

Former Executive Vice President and Chief Integrity Officer

2014

Glenn Sblendorio

Medicines

Chief Financial Officer

You may also like